Navigation Links
Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc.

BOCA RATON, Fla., Nov. 25, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product ANDA agreement with Pii (Pharmaceutics International, Inc.) (Hunt Valley, Maryland) under which Breckenridge and Pii expect to develop and commercialize several new ANDA's.  Under the terms of the agreement, Pii will develop, manufacture and supply the products, and Breckenridge will market and distribute the products under its own label.  The drugs, comprised of four unique dosage forms, and have combined U.S. market sales in excess of $1.6B, in the 12-month period ending September 30, 2014.  The multi-product agreement contemplates the submission of multiple ANDA's with Paragraph IV certifications.    

About Breckenridge:

Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products in many therapeutic categories.  The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide.  The company markets over 60 products in a variety of dosage forms and therapeutic categories. To date through 2014, Breckenridge has filed 23 ANDA's with Paragraph IV patent challenges.

About Pharmaceutics International, Inc.:

Pii (Pharmaceutics International, Inc.) is a privately held drug delivery solutions company providing dosage form development and GMP Manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley Maryland USA with European development and manufacturing facilities in the UK, Pii offers preformulation testing, formulation development and clinical trial material and commercial manufacture of parenteral, solid, semi-solid and liquid dosage forms.

SOURCE Breckenridge Pharmaceutical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Breckenridge Completes Acquisition of Certain Cypress Products from Pernix Therapeutics
2. Breckenridge Enters Into Agreement to Acquire Certain Cypress Assets from Pernix Therapeutics
3. Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macovens Discontinuance of Certain Products
4. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
5. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
6. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
7. Jazz Pharmaceuticals Announces Participation in Two Investor Conferences
8. Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants
9. Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference
10. Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market
11. Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference
Post Your Comments:
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
(Date:10/12/2017)... ... October 12, 2017 , ... Nvision Biomedical Technologies ... with the addition of industry sales leader, Thomas (Tom) Slott, as Senior Vice ... distribution and sales network, direct the efforts of the surgical sales teams, manage ...
Breaking Medicine News(10 mins):